Release Date: 06/12/12 09:35 Summary: Beneficiation Tests - SAIS has Commercially Viable Project Price Sensitive: Yes Download Document 671.94KB Download
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status